Surgeons Slowed Use of Pelvic Mesh Following FDA Warning, N.Y. Study Shows
This article was originally published in The Gray Sheet
Use of surgical mesh for pelvic organ prolapse procedures in New York state declined following a 2011 FDA warning, according to a new study.
You may also be interested in...
All members of the agency's Gastroenterology and Urology Devices Panel were convinced by Astora Women’s Health's evidence in support of PMA approval for the TOPAS mesh implant device for fecal incontinence.
Transvaginal surgical mesh scrutiny
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.